Renavance Pharma, Inc. — Form D
Renavance Pharma, Inc. of MILL VALLEY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2009-07-15. The offering totals $500K, of which $500K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2009-07-15
- Form: D
- Accession: 0001468422-09-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $500K
- Amount sold: $500K
- Investors: 1
- Date of first sale: 2009-07-01
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-132779
Issuer
- Name: Renavance Pharma, Inc.
- CIK: 0001468422
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 330 DEERTRAIL LANE, MILL VALLEY, CA, 94941
- Phone: 415 378-4099
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| John Donovan | Director | Houston, TX |
| John Donovan | Executive Officer | Houston, TX |
| Andrew Busser | Director | New York, NY |
| Mark Kessel | Director | New York, NY |
Other filings by this issuer (1)
More